Pharmacologic modulation of protein kinase C isozymes: The role of racks and subcellular localisation

Pharmacological Research

Volumn 39, Issue 4, 1999, Pages 253-259

  Csukai, Michael ^a   Mochly Rosen, Daria ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac function; Isozymes; Protein kinase C; RACKs; Translocation

Indexed keywords

ISOENZYME; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR;

CELLULAR DISTRIBUTION; DRUG SELECTIVITY; ENZYME ACTIVATION; ENZYME LOCALIZATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0033119158     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1998.0418     Document Type: Article

References (44)

1. Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 1988; 334L: 661-5.
2. Parker PJ, Kour G, Marais RM, Mitchell F, Pears C, Schaap D, Stabel S, Webster C. Protein kinase C - A family affair. Mol Cell Endocrinol 1989; 65: 1-11.
3. Newton AC. Protein kinase C: Structure, function and regulation. J Biol Chem 1995; 270: 28495-8.
4. Nakanishi H, Brewe KA, Exton JH. Activation of the zeta isozyme protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 1993; 268: 13-16.
5. Herrera-Velit P, Knutson KL, Reiner NE. Phosphatidylinositol 3-kinase-dependent activation of protein kinase C-zeta in bacterial lipopolysaccharide-treated human monocytes. J Biol Chem 1997; 272: 16445-52.
6. Geiges D, Meyer T, Marte BMV, Weissgerber G, Stabel S, Pfeilschifter J, Fabbro D, Huwiler A. Activation of protein kinase C subtypes alpha, gamma, delta, epsilon, zeta, and mu by tumor-promoting and nontumor-promoting agents. Biochem Pharmacol 1997; 53: 865-75.
7. Muller G, Ayoub M, Storz P, Rennecke J, Fabbro D, Pfizenmaier K. PKC ζ is a molecular switch in signal transduction of TNF-α, bifunctionally regulated by ceramide and arachidonic acid. EMBO J 1995; 14: 1961-9.
8. Galve-Roperh I, Haro A, Diaz-Laviada I. Ceramide-induced translocation of protein kinase C zeta in primary cultures of astrocytes. FEBS Lett 1997; 415: 271-4.
9. Sanchez P, De Carcer G, Sandoval IV, Moscat J, Diaz-Meco MT. Localization of atypical protein kinase C isoforms into lysosome-targeted endosomes through interaction with p62. Mol Cell Biol 1998; 5: 3069-80.
10. Dekker LV, Parker PJ. Protein kinase C a question of specificity. Trends Biol Sci 1994; 19: 73-7.
11. Carpenter D, Jackson T, Hanley MR. Coping with a growing family. Nature 1987; 325: 107-8.
12. Hofmann J. The potential for isoenzyme-selective modulation of protein kinase C. FASEB J 1997; 11: 649-69.
13. Mochly-Rosen D, Kauvar LM. Modulating protein kinase C signal transduction. Adv Pharmacol 1998; 44: 91-145.
14. Kraft AS, Anderson WB, Cooper H, Sando JJ. Decrease in cytosolic calcium/phospholipid-dependent protein kinase activity following phorbol ester treatment of EL4 thymoma cells. J Biol Chem 1982; 257: 13193-6.
15. Kraft AS, Anderson WB. Characterization of cytosolic calcium-activated phospholipid-dependent protein kinase activity in embryonal carcinoma cells. J Biol Chem 1983; 258: 9178-83.
16. Mochly-Rosen D, Henrich CJ, Cheever L, Khaner H, Simpson PC. A protein kinase C isozyme is translocated to cytoskeletal elements on activation. Mol Biol Cell (Formerly Cell Reg) 1990; 1: 693-706
17. Disatnik M-H, Buraggi G, Mochly-Rosen D. Localization of protein kinase C isozymes in cardiac myocytes. Exp Cell Res 1994; 210: 287-97.
18. Mochly-Rosen D. Compartmentalization of protein kinases by intracellular receptor proteins; A theme in signal transduction. Science 1995; 268: 247-51.
19. Mochly-Rosen D, Khaner H, Lopez J. Identification of intracellular receptor proteins for activated protein kinase C. Proc Natl Acad Sci USA 1991; 88: 3997-4000.
20. Mochly-Rosen D, Gordon A. Anchoring proteins for protein kinase C: A means for isozyme selectivity. FASEB J 1998; 12: 35-42.
21. Ron D, Chen C-H, Caldwell J, Jamieson L, Orr E, Mochly-Rosen D. Cloning of an intracellular receptor for protein kinase C; A homolog of the β subunit of G proteins. Proc Natl Acad Sci USA 1994; 91: 839-43.
22. Csukai M, Chen C-H, De Matteis MA, Mochly-Rosen D. The coatomer protein β′-COP: A selective binding protein (RACK) for epsilon protein kinase C. J Biol Chem 1997; 272: 29200-6.
23. Fong HK, Hurley JB, Hopkins RS, Miake-Lye R, Johnson MS, Doolittle RF, Simon MI. Repetitive segmental structure of the transducin β subunit: Homology with the CDC4 gene and identification of related mRNAs. Proc Natl Acad Sci USA 1986; 83: 2162-6.
24. Wall MA, Coleman DE, Lee E, Iñiguez-Lluhi JA, Posner BA, Gilman AG, Spang SR. The structure of the hetrotrimeric Gi α1β1γ2. Cell 1995; 83: 1047-58.
25. Pitcher J, Inglese L, Higgins JB, Arriza JA, Casey PJ, Kim C, Benovic JL, Kwatra MM, Caron MG, Lefkowitz RJ. Role of βγ subunits of G proteins in targeting the β-adrenergic receptor kinase to membrane-bound receptors. Science 1992; 257: 1264-7.
26. Ron D, Luo J, Mochly-Rosen D. C2 region-derived peptides inhibit translocation and function of β protein kinase C in vivo. J Biol Chem 1995; 270: 24180-7.
27. Souroujon M, Mochly-Rosen D. Peptide modulators of protein-protein interactions in intracellular signaling; focus on protein kinases. Nat Biotechnol 1998; 16: 919-24.
28. Johnson JA, Gray MO, Chen C-H, Mochly-Rosen D. A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function. J Biol Chem 1996; 271: 24962-6.
29. Mischak H, Goodnight J, Kolch W, Martiny-Baron G, Schaechtle C, Kazanietz MG, Blumberg PM, Pierce JH, Mushinski JF. Overexpression of protein kinase C-δ and -∈ NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence and tumorigenicity. J Biol Chem 1993; 268: 6090-6.
30. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-36.
31. + channel? Circ Res 1995; 77: 1030-5.
32. Schlaifer JD, Kerensky RA. Ischemic preconditioning: Clinical relevance and investigative studies. Clin Cardiol 1997; 20: 602-6.
33. 2+ in adult rat cardiac myocytes. Circ Res 1989; 66: 1143-55.
34. Ytrehus K, Liu Y, Downey JM. Preconditioning protects the ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994; 266: H1145-52.
35. Mitchell MB, Parker CG, Meng X, Brew EC, Ao U, Brown JM, Harken AH, Banerjee A. Protein kinase C mediates preconditioning in isolated rat heart. Circulation 1993; 88: 1633.
36. Speechly-Dick ME, Mocanu MM, Yellon DM. Protein kinase C: Its role in ischemic preconditioning in the rat. Circ Res 1994; 75: 586-90
37. Sumeray MS, Yellon DM. Myocardial preconditioning. What have we learned? Eur Heart J 1997; 18: A8-14.
38. Wilkinson SE, Hallam TJ. Protein kinase C: Is its pivotal role in cellular activation over-stated? Trends Pharmacol Sci 1994; 15: 53-7.
39. Gray MO, Karliner JS, Mochly-Rosen D. A selective epsilon protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J Biol Chem 1997; 272: 30945-51.
40. Johnson JA, Gray MO, Karliner JS, Mochly-Rosen D. An improved permeabilization protocol for introduction of peptides into cardiac myocytes: Application to protein kinase C. Circ Res 1996; 79: 1086-99.
41. Hundle B, McMahon T, Dadgar J, Chen C-H, Mochly-Rosen D, Messing R. An inhibitory fragment derived from ∈-protein kinase C prevents enhancement of nerve growth factor responses by ethanol and phorbol ester. J Biol Chem 1997; 272: 15028-35.
42. Mochly-Rosen D, Miller KG, Scheller RH, Khaner H, Lopez J, Smith BL. p65 fragments, homologous to the C2 region of protein kinase C, bind to the intracellular receptors for protein kinase C. Biochemistry 1992; 31: 8120-4.
43. Zhang Z-H, Johnson JA, El-Sherif N, Mochly-Rosen D, Boutjdir M. C2-region derived peptides of β-protein kinase C regulate cardiac calcium channel. Circ Res 1997; 80: 720-9.
44. Gerstin EH, McMahon T, Dadgar J, Messing RO. Protein kinase Cδ mediates ethanol-induced up-regulation of L-type calcium channels. J Biol Chem 1998; 273: 16409-14.